about
Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors.Inhibition of the polyamine synthesis enzyme ornithine decarboxylase sensitizes triple-negative breast cancer cells to cytotoxic chemotherapy
P50
description
researcher
@en
wetenschapper
@nl
name
Alex Toker
@en
Alex Toker
@nl
type
label
Alex Toker
@en
Alex Toker
@nl
prefLabel
Alex Toker
@en
Alex Toker
@nl
P31
P496
0000-0003-0723-4419